Ginsburg Publishes in SportsBusiness, Exploring How Rams Jerseys May Point Towards a New Area of Sports Sponsorships
15 June 2020
Associate Jarren Ginsburg authored the SportsBusiness article, “Rams jerseys point toward future NFL uniform ads,” which explored how a patch on theLos Angeles Rams’ new uniforms may preview an important new area of sports sponsorship.
In his article, Ginsburg noted a new patch on the Rams new uniforms whose contrasting colors may signal the NFL’s willingness to allow players to wear on-jersey sponsorships.
“For a long time, use of these patches on gameday, though prevalent and lucrative in international soccer leagues, had been taboo among the “Big Four” North American sports leagues. But in 2017, the National Basketball Association became the first of these leagues to adopt on-jersey sponsorships, with deals reportedly ranging from $5m to $20m annually per team…. While the NFL has not publicly stated that in-game and on-jersey advertisements will be permitted in the near future, the Rams’ jersey patch signals that the league, its clubs, and of course jersey sponsor Nike, are ready to test those waters,” he wrote.
If this theory is correct, Ginsburg continued, the NFL has likely already begun the process of developing and honing its rules for precisely which companies can sponsor on-jersey patches, and how revenue will be shared.
Read the full article here.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”